Supernus Pharmaceuticals EPS Diluted from Discontinued Operations (Quarterly) Analysis

Supernus Pharmaceuticals, Inc. (SUPN)

51.45 +0.09 (+0.18%) USD | NASDAQ | Jan 13, 16:00

51.46 +0.01 (+0.02%) After-Hours: 20:00

View EPS Diluted from Discontinued Operations (Quarterly) for SUPN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Discontinued Operations (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Discontinued Operations (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Discontinued Operations (Quarterly) Benchmarks

Start Trial

Amphastar Pharmaceuticals, Inc.	--
BridgeBio Pharma, Inc.	--
Catalyst Pharmaceuticals, Inc.	--
Assembly Biosciences, Inc.	--
Viking Therapeutics, Inc.	--